Filters
The determination of the LPA level in ovarian cancer patients (NH7666)
An implementation of methodics for the determination of the LPA level and its specification in a plasma of ovarian cancer patients by capillary electrophoresis using and in ovarian cancer patients. LPA plasma level rating in a sampl...
FN - Epidemiologie, infekční nemoci a klinická imunologie
- 2003 - 2005 •
- 501 tis. Kč •
- 500 tis. Kč •
- MZ
Řešení projektu: 1. 1. 2003 - 1. 1. 2005
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Intestinal toxicity of chemotherapy in patients with ovarian carcinoma and follow neopterin level in urine as the marker of immune system activation in patients with ovarian carcinoma (NR8156)
monitoring of intestinal toxicity during chemotherapy in patients with ovarian carcinoma by help of LAMA test and by help of xylose monitoring absorption as the marker chemotherapy in patients with ovarian carcinoma as the marker of...
FD - Onkologie a hematologie
- 2004 - 2006 •
- 1 081 tis. Kč •
- 1 075 tis. Kč •
- MZ
Řešení projektu: 1. 1. 2004 - 1. 1. 2006
Uznané náklady
Podpora ze státního rozpočtu (99%)
Poskytovatel: Ministerstvo zdravotnictví
Difference in the behaviour of the freshly isolated and cryo-preserved ovarian cancer cells and its clinical significance (NR8768)
, proliferation activity) of the freshly isolated and cryo-preserved ovarian cancer cells in the University Hospital Hradec Králové. The tissues and serum ovarian cancer patients will be stored there. Clinical significance of ov...
FK - Gynekologie a porodnictví
- 2006 - 2008 •
- 3 493 tis. Kč •
- 3 379 tis. Kč •
- MZ
Řešení projektu: 1. 1. 2006 - 31. 12. 2008
Uznané náklady
Podpora ze státního rozpočtu (97%)
Poskytovatel: Ministerstvo zdravotnictví
Characterization of genetic predisposition to ovarian cancer using genomic approaches in patients diagnosed with ovarian cancer before the age of 30 (NU20-03-00016)
Ovarian cancer is a disease with a high proportion of hereditary form. In the preceding project analyzing a gene panel in ovarian cancer patients and population with known/anticipated predisposition to ovarian cancer in pat...
Genetics and heredity (medical genetics to be 3)
- 2020 - 2023 •
- 10 063 tis. Kč •
- 10 063 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2020 - 31. 12. 2023
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Relation between thrombophilias and severe ovarian hyperstimulation syndrome (NR7810)
Objective of the project is finding of connection between development of severe ovarian hyperstimulation syndrome (OHSS) in assisted reproduction and trombophilias.......
FK - Gynekologie a porodnictví
- 2004 - 2006 •
- 1 025 tis. Kč •
- 996 tis. Kč •
- MZ
Řešení projektu: 1. 1. 2004 - 1. 1. 2006
Uznané náklady
Podpora ze státního rozpočtu (97%)
Poskytovatel: Ministerstvo zdravotnictví
Targeting ovarian tumors to experimental drugs by inhibition of CDK12 kinase activity (NV16-34152A)
Ovarian tumors represent about 16 % of all malignancies found in females occur in the majority of ovarian cancer patients converging to chemoresistant associated with pathogenesis of ovarian tumor is the cyclin-dependent ki...
FD - Onkologie a hematologie
- 2016 - 2019 •
- 9 288 tis. Kč •
- 9 288 tis. Kč •
- MZ
Řešení projektu: 1. 4. 2016 - 31. 12. 2019
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Contribution of newly characterized intermediate-risk susceptibility genes to familial breast and ovarian cancer (NT13343)
an important role in familial breast and ovarian cancer. The study will estimate the contribution of inherited mutations in these genes to familial breast and ovarian cancer to account for a higher percentage of inherited cases of ...
FD - Onkologie a hematologie
- 2012 - 2015 •
- 8 400 tis. Kč •
- 8 400 tis. Kč •
- MZ
Řešení projektu: 1. 4. 2012 - 31. 12. 2015
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Complex Care of Ovarian Carcinoma Patients (NS10258)
The project fulfils two main aims of departmental program R&D for years 2008-2011 - the individualization and control of ovarian cancer treatment using tumor for the diagnostics, control and optimization of ovarian cancer treatment....
FD - Onkologie a hematologie
- 2009 - 2011 •
- 4 668 tis. Kč •
- 4 668 tis. Kč •
- MZ
Řešení projektu: 1. 1. 2009 - 31. 12. 2011
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Molecular and genetic biomarkers of ovarian cancer pathogenesis and resistance (NT14056)
Ovarian cancer is ranked as the fourth leading cause of cancer death in women of useful molecular biomarkers for prognosis and prediction of ovarian cancer is still on the basis of gene expression profile analysis in samples of ...
EB - Genetika a molekulární biologie
- 2013 - 2015 •
- 6 853 tis. Kč •
- 6 853 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2013 - 31. 12. 2015
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Biomarkers of ovarian hyperstimulation syndrome (OHSS) in follicular fluid and plasma/serum of IVF patients - a proteomic study. (NS9781)
Objective of the project is to identify biomarkers of ovarian hyperstimultion syndrome (OHSS), a pathological response of organism to hormonal stimulation in IVF cycle, and to evaluate individual biomarkers with respect to their ability to s...
FK - Gynekologie a porodnictví
- 2008 - 2011 •
- 2 366 tis. Kč •
- 2 310 tis. Kč •
- MZ
Řešení projektu: 1. 7. 2008 - 30. 6. 2011
Uznané náklady
Podpora ze státního rozpočtu (98%)
Poskytovatel: Ministerstvo zdravotnictví
- 1 - 10 out of 107